US OptionsDetailed Quotes
NFLX241213C600000
- 313.00
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
313.00Open313.00Pre Close0 Volume2 Open Interest600.00Strike Price0.00Turnover9459.08%IV-0.64%PremiumDec 13, 2024Expiry Date318.87Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9942Delta0.0001Gamma2.88Leverage Ratio-930.9654Theta0.0000Rho2.86Eff Leverage0.0003Vega
Netflix Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
As 2024 wraps up, U.S. stocks have seen a robust rally, with the $S&P 500 Index (.SPX.US)$ climbing over 26% year-to-date. This surge was driven by the AI boom and strategic plays in rate cuts, Trump-related trades, and recession hedges, each taking the spotlight at different times.
AI advertising firm $Applovin (APP.US)$ led gains with an almost 750% rise. AI data analytics company $Palantir (PLTR.US)$ jumped more than 320%, w...
AI advertising firm $Applovin (APP.US)$ led gains with an almost 750% rise. AI data analytics company $Palantir (PLTR.US)$ jumped more than 320%, w...
66
2
62
$Nasdaq Composite Index (.IXIC.US)$surged nearly 2%, breaking 20,000 for the first time, while $Dow Jones Industrial Average (.DJI.US)$declined. $Tesla (TSLA.US)$ led tech giants to record highs, with Tesla and $Alphabet-C (GOOG.US)$up nearly 6%, joined by $Meta Platforms (META.US)$ , $Amazon (AMZN.US)$ , and $Netflix (NFLX.US)$ at new peaks. The semiconductor index gained nearly 3%, with $NVIDIA (NVDA.US)$up over 3% and $Broadcom (AVGO.US)$nearly 7%. $Apple (AAPL.US)$ hit a record high before r...
5
1
The U.S. CPI data released today met market expectations, which is expected to further increase the probability of a Federal Reserve rate cut in December. Catalyzed by this news, the $Nasdaq Composite Index (.IXIC.US)$ successfully broke through the 20,000-point mark, reaching a historic new high and entering a new milestone. Year-to-date, the Nasdaq has accumulated a 35.45% gain, leading the major U.S. stock indices.
Looking back at 2024, ...
Looking back at 2024, ...
49
1
17
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.